Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver

BMC Gastroenterology

Research Article

Janine Poranzke¹  Kerstin Schütte¹  Jan Bornschein¹  Peter Malfertheiner¹  Christian Schulz¹  Jörg Arend²  Tina Bretschneider³  Jens Ricke³  Kai Antweiler⁴ 

[1] Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Germany;Department of General, Visceral and Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany;Department of Radiology and Nuclear Medicine, Otto-von-Guericke University, Magdeburg, Germany;Institute for Biometry and Medical Informatics, Otto-von-Guericke University, Magdeburg, Germany;

关键词: Hepatocellular carcinoma;    Prognosis;    Liver cirrhosis;    Non-cirrhotic liver;    NAFLD;   

DOI  :  10.1186/1471-230X-14-117

 received in 2014-02-23, accepted in 2014-06-26,  发布年份 2014

来源: Springer

【 摘 要 】

BackgroundHCC predominantly develops in the condition of chronic inflammation that has led to liver cirrhosis. A small proportion of patients with HCC is diagnosed in the non-cirrhotic liver (NCL). Data on patients with HCC in NCL in advanced stages are scarce.MethodsA retrospective analysis was performed comparing 93 patients with HCC in NCL to 571 patients with HCC in liver cirrhosis (LC) with respect to clinical and demographic characteristics. Also factors influencing survival in patients with HCC in NCL were analyzed.ResultsPatients with HCC in NCL were diagnosed at older age and in more advanced tumor stages than patients with LC. More than 25% of patients with HCC in NCL presented with extrahepatic metastases. Only a minority of patients with HCC in NCL lacked any sign of hepatic damage. Risk factors for LC and risk factors for NAFLD are present in the majority of patients with HCC in NCL. The BCLC classification corresponded with the survival of patients with HCC in NCL although the therapeutic options differ from those for patients with liver cirrhosis.ConclusionsIt will be one of the major challenges in the future to awake awareness of carrying a risk of hepatic malignancies in patients with chronic liver diseases apart from liver cirrhosis, especially in NAFLD. Surveillance programs need to be implemented if these are cost-effective.

【 授权许可】

Unknown   
© Schütte et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.